We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MRI-Guided Focused Ultrasound System Burns Breast Cancer Tumors without Surgery

By MedImaging International staff writers
Posted on 11 Oct 2023
Print article
Image: Patient being treated with the MUSE breast cancer ablation system (Photo courtesy of University of Utah Health)
Image: Patient being treated with the MUSE breast cancer ablation system (Photo courtesy of University of Utah Health)

In a significant breakthrough in the field of non-invasive treatments for breast cancer, scientists have developed a technology capable of eliminating tumors without the need for surgical intervention, all within an outpatient setting.

The MUSE breast cancer treatment system developed by researchers from the Huntsman Cancer Institute at University of Utah Health (Salt Lake City, UT, USA) employs a two-step, non-surgical approach for locating and ablating, or removing, breast tumors. Initially, magnetic resonance imaging (MRI) is utilized to identify and pinpoint the tumors. Once the tumors are located, focused ultrasound technology is used to heat and subsequently destroy the cancerous cells. The entire treatment, which allows the patient to stay awake, takes about 90 minutes and is completed within a few hours.

Designed with patient comfort in mind, the MUSE system incorporates a special table for use during the MRI. The specialized device focuses ultrasound waves into a specific area of the tumor. These waves heat the cancerous tissue in intervals of 30 seconds, and are directed to cover the whole tumor. Currently in its phase 1 clinical trials, the first patient in the U.S. was treated using the MUSE system in a pioneering clinic trial in February 2023. The research team anticipates that it will take at least five years to advance through phase 3 clinical trials before MUSE becomes commercially available as a surgery-free option for treating breast cancer.

“The purpose of the current study is to see how well patients tolerate the ablation, basically how much pain they have during the procedure,” said Cindy Matsen, MD, breast surgeon at Huntsman Cancer Institute, who is the principal investigator for this clinical trial. “We’ll also be looking at the tissue after surgery to see how effective the ablation was. Only 50% is being ablated at this point to make sure we can still do tests that may be needed on the tumor afterwards. In the future, we hope this ablation will be effective enough to replace surgery for some women.”

Related Links:
University of Utah Health 

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Radiology Software
DxWorks
New
Portable Color Doppler Ultrasound System
S5000
New
Transducer Covers
Surgi Intraoperative Covers

Print article
Radcal

Channels

Radiography

view channel
Image: The new X-ray detector produces a high-quality radiograph (Photo courtesy of ACS Central Science 2024, DOI: https://doi.org/10.1021/acscentsci.4c01296)

Highly Sensitive, Foldable Detector to Make X-Rays Safer

X-rays are widely used in diagnostic testing and industrial monitoring, from dental checkups to airport luggage scans. However, these high-energy rays emit ionizing radiation, which can pose risks after... Read more

Nuclear Medicine

view channel
Image: Example of AI analysis of PET/CT images (Photo courtesy of Academic Radiology; DOI: 10.1016/j.acra.2024.08.043)

AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer

Immunotherapy has significantly advanced the treatment of primary lung cancer, but it can sometimes lead to a severe side effect known as interstitial lung disease. This condition is characterized by lung... Read more

General/Advanced Imaging

view channel
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.